Results 241 to 250 of about 206,338 (257)

Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales

British Journal of Pharmacology, 2013
Asmaâ El-Kenawi, Azza B El-Remessy
exaly  

The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; A review

European Journal of Cancer, 2006
Ferry A L M Eskens, Jaap Verweij
exaly  

Angiopoietin inhibitors: A review on targeting tumor angiogenesis

European Journal of Pharmacology, 2021
exaly  

Maximizing the Efficacy of Angiogenesis Inhibitors

Journal of Clinical Oncology, 2012
Jason W, Locasale, Benjamin J, Zeskind
openaire   +2 more sources

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Interfere With Angiogenesis by Inhibiting the Geranylgeranylation of RhoA

Circulation Research, 2002
Ho－Jin Park, M Luisa Iruela-Arispe, Jonas B Galper   +2 more
exaly  

Novel endogenous angiogenesis inhibitors and their therapeutic potential

Acta Pharmacologica Sinica, 2015
Ruowen Ge
exaly  

Angiogenesis

Annual Review of Medicine, 2006
Judah Folkman
exaly  

Angiogenesis Inhibitors

2013
Nikita Minhas, Chris John Jackson, Meilang Xue   +2 more
openaire   +1 more source

Angiogenesis inhibitors in early development for gastric cancer

Expert Opinion on Investigational Drugs, 2017
Mauricio P Pinto, Gareth I Owen, Ignacio N Retamal   +2 more
exaly  

Discovery of novel anti-angiogenesis agents. Part 6: Multi-targeted RTK inhibitors

European Journal of Medicinal Chemistry, 2017
Yuanyuan Shan, Lisha Li, Xiaoyan Pan
exaly